Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Sung‐Bae Kim(University of Ulsan), Rebecca Dent(National Cancer Centre Singapore), Seock‐Ah Im(Seoul National University Hospital), Marc Espié(Hôpital Saint-Louis), Sibel Blau(Northwest Medical Specialties), Antoinette R. Tan(Levine Cancer Institute), Steven J. Isakoff(Massachusetts General Hospital), Mafalda Oliveira(Vall d'Hebron Hospital Universitari), Cristina Saura(Vall d'Hebron Hospital Universitari), Matthew Wongchenko, Amy V. Kapp, Wai Yee Chan, Stina Mui Singel, Daniel Maslyar(Asan Medical Center), José Baselga(Memorial Sloan Kettering Cancer Center), Sungbae Kim(University of Ulsan), Keun Seok Lee, Seock‐Ah Im(Seoul National University Hospital), Marc Espié(Hôpital Saint-Louis), Hwei-Chung Wang, Sibel Blau(University of Washington), Rebecca Dent(National Cancer Centre Singapore), Antoinette R. Tan(Carolinas Healthcare System), Joohyuk Sohn, Michelino De Laurentiis, Laura García‐Estévez, Chiun‐Sheng Huang, Gilles Romieu, Michel Velez, Rafael Villanueva-Vázquez, Pierfranco Conté, Shaker R. Dakhil, Marc Debled(Hôpital Saint-Louis), Antonio González-Martı́n, Sara A. Hurvitz, Jee Hyun Kim(University of Ulsan), Christelle Lévy, Mafalda Oliveira(Vall d'Hebron Institute of Oncology), Pedro Sánchez‐Rovira, Jae Hong Seo(Seoul National University Hospital), Vicente Valero, Gregory A. Vidal, Andrea Wong, Mary Ann Allison, Robert A. Figlin, David Chan, Shin‐Cheh Chen, Yen‐Hsun Chen, Melody Cobleigh, Filippo de Braud, Luc Dirix, Vincent Hansen, Anne Hardy Bessard, Nicholas Iannotti, Steven J. Isakoff(Massachusetts General Hospital), William Lawler, Álvaro Montaño, Mohamad Salkini, L. Seigel
Cited by 474Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis